| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429209A Disulfide derivatives useful for treating allergic diseases |
| 07/09/2003 | CN1429208A Aniline disulfide derivatives for treating allergic diseases |
| 07/09/2003 | CN1429206A 磺酰胺衍生物 Sulfonamide derivatives |
| 07/09/2003 | CN1429205A 磺酰胺衍生物 Sulfonamide derivatives |
| 07/09/2003 | CN1429203A Sponge antitumor compounds |
| 07/09/2003 | CN1429202A Compounds for modulating cell proliferation |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1429197A Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 07/09/2003 | CN1429126A Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 07/09/2003 | CN1429120A Stable polymeric micelle-type drug composition and method for preparation thereof |
| 07/09/2003 | CN1429119A Method for preparation of polymeric micelle via separation of block copolymer |
| 07/09/2003 | CN1429118A Aromatase inhibitors and monoclonal anti-HER2 anti-bodies as antitumors agents |
| 07/09/2003 | CN1429114A 联合化学疗法 Combined chemotherapy |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 07/09/2003 | CN1429112A Composition for use in treatment of ocular hypertension and glaucoma |
| 07/09/2003 | CN1429111A Methods for inhibiting proliferation and inducing apoptosis in cancer cells |
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1429109A Compositions comprising blockers of L-DOPA renal cell transfer for treatment of Parkinson's disease |
| 07/09/2003 | CN1429108A 磷酸盐运输抑制剂 Phosphate transport inhibitor |
| 07/09/2003 | CN1429107A Compositions cotaining benzamide disulfide derivative for treating allergic diseases |
| 07/09/2003 | CN1429106A Methods for inhibiting angiogenesis and tumor growth |
| 07/09/2003 | CN1429105A Dermal compositions containing coenzyme Q as active ingredient |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/09/2003 | CN1429103A Novel process |
| 07/09/2003 | CN1429102A Hydrogel composition for transdermal drug delivery |
| 07/09/2003 | CN1429101A Stabilized aqueous suspensions for parenteral administration |
| 07/09/2003 | CN1429098A 乳化组合物 Emulsified composition |
| 07/09/2003 | CN1429097A Use of ellagic acid as anti-pollution cosmetic agent |
| 07/09/2003 | CN1428426A Programmed cell death induction molecule II |
| 07/09/2003 | CN1428350A Antineoplastic compound Intercedenside C in bicolor table ginseng |
| 07/09/2003 | CN1428340A 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method |
| 07/09/2003 | CN1428336A Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 07/09/2003 | CN1428334A Alkaloid compound, pain-stopping medicine and its preparation method |
| 07/09/2003 | CN1428166A Chinese medicine composition for curing AIDS and its preparation mehtod |
| 07/09/2003 | CN1428146A Injection containing tramadol and its application |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113966C Fermentation method for preparing acabose by osmosis control |
| 07/09/2003 | CN1113912C Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 07/09/2003 | CN1113895C Growth hormone secretagogues |
| 07/09/2003 | CN1113891C Anti-tumour antibiotic and microbiological formentation production method |
| 07/09/2003 | CN1113888C Tetraphosphonate bicyclic trisanhydrides |
| 07/09/2003 | CN1113885C Process for producing beta-lactam derivs. |
| 07/09/2003 | CN1113882C Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 07/09/2003 | CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives |
| 07/09/2003 | CN1113879C Method for synthesis of benzimidazole compound |
| 07/09/2003 | CN1113877C Effective synthetic method for furau sulfonic acid amide compound for synthesizing new IL-1 inhibitor |
| 07/09/2003 | CN1113874C Benzocycloalkylazolethione derivatives |
| 07/09/2003 | CN1113873C Novel optionally substitued phenylimidazolidines, intermediates and process for prepn. thereof, use as druge and pharmaceutical composition contg. same |
| 07/09/2003 | CN1113872C Tricyclicbenzo [e] isoindole and benzo [h] isoquinoline |
| 07/09/2003 | CN1113871C 9-aminoacridine derivatives and process for preparation thereof |
| 07/09/2003 | CN1113870C Preparation of butylthio-isoquinoline and intermediate thereof |
| 07/09/2003 | CN1113869C Two aporphine-benzyl isoquinoline compounds with antitumour activity |
| 07/09/2003 | CN1113867C Amino anthracyclinone derivatives and their use in treatment of amyloidosis |
| 07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
| 07/09/2003 | CN1113856C New [(3-alkoxy-phenoxy)-ethyl] dialkylamine derivatives and their use as local anaesthetics |
| 07/09/2003 | CN1113675C Metered dose inhaler for fluticasone propionate |
| 07/09/2003 | CN1113669C Method for treating endothelial injury |
| 07/09/2003 | CN1113665C Inflammation diminishing and stone dissolving and exhausting liquid and its preparing method |
| 07/09/2003 | CN1113654C Compounds and pharmaceutical compositions containing them |
| 07/09/2003 | CN1113653C Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents |
| 07/09/2003 | CN1113652C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and treating human malignant tumour |
| 07/09/2003 | CN1113651C Orally applicable formulation of quinolone or naphthyridone carboxylic acids |
| 07/09/2003 | CN1113650C Drug composition of self-emulsifying agent form lipophilic compounds |
| 07/09/2003 | CN1113649C Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 07/09/2003 | CN1113648C Use of tetrahydro-beta-carboline derivative as antimetastatic carcinoma preparation |
| 07/09/2003 | CN1113647C Polyether antitoxin medicine use for antituberculosis and antileprosy |
| 07/09/2003 | CN1113646C Medicinal preparation containing shikimic acid and its derivatives, and its use in preparing anti-thrombosis and analgesic medicine |
| 07/09/2003 | CN1113599C Antimicrobial treatment method for herpes simplex virus and other infectious diseases |
| 07/08/2003 | US6590109 Suspending plant material or extract in presence of oxidation reagent, extracting terpene trilactones using acceptable extraction agent, separating organic layer from aqueous layer to isolate terpene trilactones in organic layer |
| 07/08/2003 | US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits |
| 07/08/2003 | US6590093 Orthoester protecting groups |
| 07/08/2003 | US6590085 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/08/2003 | US6590083 Compounds of given formula; erythromycin derivatives; useful in the treatment of bacterial and protozoal infections and conditions involving gastric motility |
| 07/08/2003 | US6590071 Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 07/08/2003 | US6589997 Small-molecule modulators of hepatocyte growth factor/scatter factor activities |
| 07/08/2003 | US6589996 Treatment of disorders relating to the serotonergic system |
| 07/08/2003 | US6589995 Method of inhibiting pancreatic β-cell p135 O-glycosylation |
| 07/08/2003 | US6589994 Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound |
| 07/08/2003 | US6589993 Treating vancomycin-intermediates and multiresistant staphylococci infection with thiamphenicol or a salt thereof |
| 07/08/2003 | US6589992 2-Cyano-3-hydroxy-3-methyl-N-(2,5-dibromophenyl)propenamide; does not affect thrombin-induced aggregation; inhibits Bruton's tyrosine kinase cardiovascular, hematopoietic and brain disorders at risk for thromboembolic complications. |
| 07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/08/2003 | US6589990 Topically administering to penis to treat sexual disorder |
| 07/08/2003 | US6589989 Treating chronic hand eczema in a human patient in need of treatment, using oral administration of 9-cis retinoic acid and pharmaceutically acceptable salts and pharmaceutically acceptable hydrolysable esters thereof, in an effective |
| 07/08/2003 | US6589988 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 07/08/2003 | US6589987 Dithiocarbamate, particularly tetraethylthiuram disulfide strongly inhibits the growth of cancer cells of a variety of cell types. Such inhibitory effect is enhanced by heavy metal ions such as copper ions, cytokines and ceruloplasmin and |
| 07/08/2003 | US6589986 Methods of treating anxiety disorders |
| 07/08/2003 | US6589985 Halogenated 2-phenyl-1,2-ethanediol monocarbamate or dicarbamate compounds |
| 07/08/2003 | US6589984 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as |
| 07/08/2003 | US6589983 Antiarrhythmic agents having the prolongation effect on the functional refractory period as a main function |
| 07/08/2003 | US6589982 Flavones with an isoprenyl group in the 8-position are used as the active ingredient to make a food or food supplement suitable for the treatment/ prevention/or to cure inflammatory diseases or skin disorders |
| 07/08/2003 | US6589981 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 07/08/2003 | US6589979 Derivatives of seco-baccatine III, with bioavailability through the oral route, reduced toxicity and high antiangiogenetic activity; use as antiarthritic agent as well |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects |
| 07/08/2003 | US6589971 A method of treatment of a neoplastic disease in a patient in need of said treatment by administering a therapeutically effective amount of a compound of the formula: bind to specific sequences in the minor groove of duplex DNA, and to |
| 07/08/2003 | US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 07/08/2003 | US6589966 A family of hexadentate Fe(II) chelators having marked antiproliferative activity against tumor cells is disclosed. The cytotoxic metal chelators and complexes of the present invention are represented by the general formula below: |
| 07/08/2003 | US6589965 Method of treating and preventing migraine headaches |
| 07/08/2003 | US6589964 Method for enhancing mutant enzyme activities in lysosomal storage disorders |